Tuesday, 15 October 2019

FDA Approves Octapharma's WILATE® for Hemophilia A in Adult and Adolescent Patients - Business Wire

FDA Approves Octapharma's WILATE® for Hemophilia A in Adult and Adolescent Patients  Business Wire

No comments:

Post a Comment